Myeloproliferative disorders

Last Modified: December 1, 2002


Dear OncoLink "Ask The Experts,"
I have a friend who was just diagnosed with MPD. Could you please send me information on what the disorder is exactly? 


Selina M. Luger, MD, Director of the Leukemia Program and Assistant Professor of Medicine at the University of Pennsylvania, responds:

MPD means myeloproliferative disorder. In these patients, typically there is an increase in the number of cells being made by the bone marrow resulting in increased blood counts. There can be an increase in the white blood cells, hemoglobin, or platelet counts or a combination of these. Sometimes patients will have enlarged spleens. Depending on the specific manifestations of the patient's disorder as well as the results of additional testing that may be done on the blood or bone marrow, the physician will determine how to treat the patient.


7 Tips for Giving Smart on #givingtuesday
by Christina Bach, MSW, LCSW, OSW-C
November 25, 2015

Related News

STAT3 Mutations ID'd in Rare Lymphoproliferative Disorder

May 18, 2012

Four specific mutations in SH2 domain seen in T-cell large granular lymphocytic leukemia

ASH: CALR Mutations ID'd in Myeloproliferative Neoplasms

Dec 11, 2013

Two studies show somatic mutations in CALR for most patients with nonmutated JAK2

Fatigue and sleep disorders increase risk of neurocognitive impairment

Apr 12, 2011

Fatigue and sleep disorders increase risk of neurocognitive impairment